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Abstract
Background: The addition of medications for enhanced epidural analgesia is a well-known topic. Many
medications have been studied including steroids, opioids, clonidine, precedex and others. Using
Neostigmine has been hypothesized to enhance the efficacy of analgesia without some of the side effects
associated with opioid use and risks of Local anesthetic systemic toxicity (LAST) from large Local
Anesthetic (LA) requirements. Neostigmine administration in conjunction with alternative medications in
neuraxial anesthesia is associated with a reduced dosage of LA required during labor and postoperatively
following cesarean section. Studies have shown how neuraxial administration of neostigmine significantly
minimized local anesthetic usage without causing serious negative side effects.

Methods: A detailed search strategy encompassed the databases CINAHL, Cochrane Library and
PUBMED. Articles found to be eligible for review were found to fit within the constraints of the original
PICO question. Population (P): Anesthesia Providers who participate in epidural management,
Intervention (I): Educating about epidural Neostigmine analgesia, Comparison (C): Comparing epidural
neostigmine knowledge before and after education, Outcome (O): Improve provider knowledge on
methods to improve analgesia when additional local analgesia is contraindicated or opioid puritis is
unwanted. These abstracts and titles were reviewed to include only randomized control trials. A total of
seven articles were chosen and were deemed fitting within the PICO constraints.

Results: Participants were asked the likelihood to use alternative therapies rather than local anesthetics
and opioids to enhance epidural analgesia. Two participants (40%) said extremely likely. An additional
two participants (40%) said somewhat likely and one participant (20%) said neither likely nor unlikely.
This showed that practitioners are willing to try alternative approaches to enhance epidural analgesia if
patients will benefit. Additionally, participants were asked the likelihood that after watching the video on
epidural neostigmine for enhanced analgesia, would the participant be willing to use neostigmine in their

6
daily practice. Based upon the results, two participants would be extremely likely to use epidural
neostigmine. This result shows that the YouTube presentation provided a positive educational experience
which may influence practitioners to consider epidural neostigmine in their pharmacological arsenal.

Keywords: EPIDURAL ANALGESIA; NEURAXIAL ANALGESIA; NEOSTIGMINE; OPIOID;
ACETYLCHOLINE.

Problem Statement
Additional medications are often administered in addition to local anesthetics in efforts of
enhancing epidural or spinal analgesia. These additional medications range from opioids to
clonidine and even neostigmine. Pruritis can be a common unwanted side effect when intrathecal
and epidural opioids are administered.6 The incidence of pruritis can vary between 30% and
100%.6 The exact mechanism of neuraxial opioid-induced pruritus is not totally understood.6 The
addition of opioids does enhance analgesia however the risk of pruritis can be severe for some. If
patient preference opposes opioid usage due to their negative side effect profile, then
practitioners can only rely on additional local anesthetics (LAs) or higher concentrations.
However, epidural anesthesia and peripheral nerve blocks (PNBs) require high volumes of LAs
and this inherently raises the possibility for local anesthetic systemic toxicity (LAST).5 If a
practitioner has already met the upper limits of allowable LA dosing then the extent of the block
cannot be made denser if the patient refuses opioids due to past experiences such as pruritis.
Scope of the problem
A study was performed regarding the occurrence of pruritis among women receiving epidural
management for cesarean section with the addition of opioids. From this study, 89% of the
women who received morphine and 71% of the women who received fentanyl had severe pruritis
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which required treatment.7 These percentages show how common and frequent this undesirable
side effect can occur. Additional problems that arise regard the issue of insufficient analgesia.
Often, women who plan for a vaginal birth are forced to convert to cesarean for various reasons.
Many of these women already have an epidural catheter in place. One study mentioned how
many times epidural labor analgesia fails to convert to adequate epidural surgical analgesia.8 The
study found that epidurals fail to provide surgical analgesia 15% of the time while spinals fail
2% of the time.9
In addition to the failure of analgesia, if practitioners increase the dosage of LA, they run the
risk of high levels and LAST. Current data indicated that the incidence of LAST associated with
PNBs has decreased from 1.6–2 for every 1000 patients in the 1990s to roughly 0.9 for every
1000 between 2003 and 2013.5 The incidence of LAST with epidural anesthesia decreased from
9.75 out of 1000 in the early 1980s to 0.1 out of every 1000 in the 1990s.5 These trends show
great improvements, but all possible risks are not eliminated.
Additional statistics show how dangerous LA dosages can be when handled incorrectly. A
2009 study revealed close-claim circumstances were anesthesiologist have been sued.11 They
reported 10 instances where a high spinal occurred due to epidural catheters placed intrathecally
and were not recognized due to failure to aspirate or utilize a lidocaine test dose with
epinephrine.11 Additionally, there were two circumstances of high spinals and three instances of
high epidural blockade.11 The severity of consequences that can occur when regional anesthesia
goes wrong cannot be underestimated. This study also revealed events where anesthesia
providers were not adequately prepared to treat hypotension or airway emergencies when
performing epidural placement.11 Four of these cases resulted in patients requiring transfer to the
operating room for resuscitation due to inadequate material in the labor room.11
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Consequence of the problem

A high proportion of obstetric malpractice claims is the result of pain during anesthesia
compared to nonobstetric claims.9. Circumstances arise were labor is escalating rapidly and the
sacral blockade efficacy may not suffice. During these circumstances, large volumes of local
anesthetic may improve sacral analgesia.9 However if the efficacy of sensory blockade is optimal
but the patient is still expressing pain, then the blockade’s density may be inadequate.9 These
instances can be resolved with the administration of a more concentrated local anesthetic. 9
However these options in efforts of deepening the block run the possibility of high levels and
possibly reaching the upper limit of safe LA dosages.

A review of cases since 1995 showed Anesthesia-related claims account for 2.5% of all claims
and 2.4% of the value of all claims. Of 841 relevant claims, 44% were related to regional
anesthesia, 29% obstetric anesthesia, and 20% were due to inadequate anesthesia.10 This review
was performed by the National Health Service Litigation Authority (NHSLA) which manages
legal claims made against NHS Hospital Trusts, Foundation Trusts and Primary Care Trusts in
the United Kingdom.10 Claims-related costs have risen from $454 million in 2004-2005 to $585
million in 2006 through 2007.10 The claims with the highest overall values were regional
anesthesia recorded at $15 million and $10.38 million for obstetric anesthesia.10
Knowledge Gaps
Accidental subarachnoid injection of large doses of local anesthetics can have disastrous
effects. These large unintentional doses can lead to a high spinal, which is characterized as
extreme hypotension, syncope, and apnea due to brain stem hypoperfusion.9 Therapy includes
mechanical ventilation, fluid management and inotropes. Administration of ionotropic drugs
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such as epinephrine may be required if cardiac sympathetic blockade occurs resulting in
bradycardia.9 Additionally, pregnant mothers are at higher risks for unintended intravenous
catheter insertion during regional anesthesia because of epidural vein engorgement. Statistically,
accidental intravascular epidural catheter insertion may occur in as many as 7% to 8.5% in the
obstetric population.9
Proposal solution
The proposed solution for this DNP is the administration of neostigmine in efforts of
enhancing analgesia while avoiding higher LA doses and the side effects of opioids. One study
showed sampled Cerebrospinal fluid (CSF) via an indwelling spinal catheter in 12 volunteers
receiving intrathecal neostigmine (50-750 mcg) and analyzed the presence of neostigmine and
acetylcholine.1 Analysis of the CSF samples were performed and found increased acetylcholine
concentrations from <20 pmol/ml at baseline to >100 pmol/ml within 15 min of neostigmine
injection.1 A 2009 randomized control study by Ross and colleagues evaluated the requirements
of epidural bupivacaine infused with neostigmine in obstetrics.3 The data showed that adding 40
mcg/mL of epidural neostigmine reduced the hourly bupivacaine requirement by 19%-25% with
patient-controlled epidural analgesia during labor.
Using Neostigmine can enhance the efficacy of analgesia without some of the side effects
associated with opioid use and risks of LAST from larger LA requirements. The intravenous use
of opioids reduce pain and increase the release of acetylcholine in the spinal cord’s dorsal horn.2
This effect has also been proven to be enhanced with the injection of intrathecal neostigmine.2
Neostigmine administration in conjunction with alternative medication in neuraxial anesthesia is
associated with a reduced dosage of LA required during labor and postoperatively following
cesarean section.4 This study showed how neuraxial administration of neostigmine significantly
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minimized local anesthetic usage without causing serious negative side effects to the fetus or
mother.4 However, due to the occurrence of nausea and vomiting when given subarachnoid,
neostigmine should only be given via the epidural route.4
An additional 1997 RCT by Hood and colleagues evaluated analgesia in intrathecal
neostigmine and intravenous (IV) alfentanil.2 IV alfentanil caused respiratory depression that
was not observed via epidural neostigmine and additionally enhanced analgesia. Intravenous
alfentanil increased cerebrospinal fluid ACh concentration, and neostigmine was noticed to
enhance this change a well.2 This data regarding neostigmine is consistent with the spinal
cholinergic mechanism that is observed with IV opioid analgesia.2

Results
Study Characteristics
The six articles that were chosen were all Level I studies due to their RCT design. The
articles all evaluated the use of epidural neostigmine, with one article, (Rocha et al., 2014)
evaluating intrathecal neostigmine. This article was included due to the minimal dosage of
neostigmine utilized and its literature review acknowledging the awareness of nausea and none
of the participants experiencing nausea from intrathecal neostigmine. All the studies evaluated if
less analgesics were required by the participants or if extended time was recorded before rescue
analgesics were required after neostigmine administration.
Results of Individual Studies
The 2009 study from Ross and colleagues evaluated the hypothesis that epidural
neostigmine in combination with bupivacaine via continuous infusion would minimize the
amount of required bupivacaine. The study was of level one quality due to its randomized
control trial. The study evaluated 40 women who blindly received solely 1.25 mg/ml
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Bupivacaine or with the addition of 4 mcg/ml neostigmine. The primary outcome to be measured
would be the hourly usage of bupivacaine. There findings revealed that the group that received
neostigmine added to their infusion used 19% less bupivacaine in all participants and 25% in
those who continued the infusion greater than 4 hours. The study also monitored for any possible
negative muscarinic side effects on the fetus. They found no evidence of increased risk of nausea
and vomiting, uterine contractions, or fetal heart abnormalities. The only side effect noticed was
an increase level of sedation among the women. The first phase of this study was to find a safe
dose of neostigmine that would not produce unwanted side effects for the mother or fetus. The
first phase analyzed the safety between a 40 mcg and 80 mcg dose of neostigmine for 12 women.
One woman in each group experienced nausea but was reported to be minimal on a 1-10 grading
scale. The women for the second phase of the experiment ranged from ages of 21-36. There was
no difference in demographic or labor characteristics. All women were cervically dilated roughly
3 cm. This could influence the efficacy of the block. If women were further along and
experiencing more sever labor pain, thus requiring a stronger rescue of analgesia, maybe the
addition of neostigmine wouldn’t be enough to lower bupivacaine requirements. The women that
were eligible for this study had to be ASA I or II, less than 114kg, single fetus, and cervical
dilation less than 6 cm. The study was limited to healthy individuals and of women experiencing
only labor pain. This study does not analyze the effectiveness of epidural neostigmine for postop
analgesia used in other surgeries.
A 2014 article conducted between Rocha and colleagues, performed a Level one
evidence study due to its RCT structure, evaluating 60 individuals. The study randomly selected
60 individuals to one of four groups. The control group (CG) received a spinal and epidural
saline. The Neostigmine group (NG) received spinal neostigmine and epidural saline. The
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Dexamethasone group (DG) received spinal saline and epidural dexamethasone. Lastly, the
Neostigmine dexamethasone group (NDG) received spinal neostigmine and epidural
dexamethasone. All groups received 15mg of Bupivacaine intrathecally and measured the time
for their first rescue dose and amount of rescue medication required. The results concluded that
DG had the longest time for first rescue dose compared to NG and CG. The results also
concluded that the addition of neostigmine in the NDG group resulted in even longer times
before rescue relief was required, and less medication needed. This study aimed at evaluating if
additional medications could enhance analgesia compared to opioids which are known for their
adverse effects. The study mentioned how neostigmine may be more effective in treating somatic
pain versus visceral pain, and this could be beneficial for orthopedic procedures.3 Additionally,
epidural dexamethasone has been known to be more beneficial at treating visceral and
neuropathic pain compared to somatic.3 The candidates chosen were of ASA I and II, ranging
from ages 15-60 years old. Their pain was ranked on visual analog score from 0-10. The rescue
drug that could be requested at any time was 50 mg of ketoprofen every 4 hours, and the second
rescue drug was 1 g dipyrone. Pain was recorded at the time of the spinal and the time of first
requested rescue analgesia. Nausea and vomiting were recorded and ranked by the
anesthesiologist who was blind to the treatment. The surgery the candidates underwent were
minor orthopedic procedures ranging from knee arthroscopy, meniscus repair, and knee
ligamental reconstruction. The use of 5-10 mg of epidural dexamethasone was the recommended
dose. The study found that 30% of patients in the DG group did not request rescue medications
and with the addition of 1 microgram of spinal neostigmine, this statistic was increased to 60%
of the participants in the NDG group not requesting rescue medications. The study mentioned
how they were the 3rd study to show evidence of enhancement of opioid analgesia after

13
neostigmine and the first clinical trial to show furth enhancement of analgesia in combination
with epidural dexamethasone. The mechanism of action for which this study claims neostigmine
has its analgesic effects is multimodal. It is believed to increase Acetylcholine concentration at
the M1 and M3 receptors present in Laminae II and V in the dorsal horn. This affect was
believed to be mediated partly by GABA receptors in the dorsal horn. Neostigmine was also
shown to induce Nitric Oxide release which inhibited FOS expression and activated M2
receptors, which in turn released catecholamines, thought to produce anti-inflammatory effects at
the tissues.
A 2017 randomized, double blind study was performed by Booth and colleagues. The
study aimed at evaluating the efficacy between epidural neostigmine and epidural fentanyl when
added to Bupivacaine. The study mentioned how epidurally placed opioids are known to
decrease local anesthetic requirement up to 20% but at the expense of unwanted side effects. The
hypothesis of the study was to see if epidural bupivacaine usage would be similar between
neostigmine addition and fentanyl addition. The participants that were included were 215 ASA II
laboring mothers, who were requesting epidural analgesia. The groups were to receive .125%
Bupivacaine with 2mcg/ml fentanyl, or neostigmine (2, 4 or 8mcg/ml). The measured outcome
was total hourly local anesthetic consumption, including top offs. The total amount of
administered medication was divided by the number of hours administered. The results only
found 151 participants to be eligible for evaluation in the study. The researchers monitored the
maternal and fetal outcomes and found no significant difference between the groups. The
evidence supported no hourly difference in Bupivacaine requirements whether the groups
received fentanyl or neostigmine. The researchers mentioned how opioids are useful for
minimizing local anesthetic dosages and minimizing hypotension and motor blockade, but they
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themselves can cause puritits and decreases in fetal heart rate variability. They mentioned how
neostigmine, since the 1990s, has been known intrathecally to provide effective analgesia,
however at the cost of severe nausea and vomiting. The authors mentioned, how when
neostigmine is administered epidurally rather than intrathecally, the unwanted side effects of
nausea and vomiting are not observed. Additional inclusion criteria for this study were women
with only single fetus, weight less than 115kg, cervical dilation less than 5cm, and not having
received IV analgesics within 60 minutes of the epidural. If the women complained of pain
greater than 3 on a pain score of 0-10, the women were excluded from the study and the catheter
was removed and discretion was left to the anesthesiologist. All care members involved in the
care were blind to the study and except for the anesthesiologist who mixed the epidural solutions.
All participants were placed on a 6 ml/hr basal rate with a possible 5ml bolus with a 10 minute
lockout period. Patients requiring more than one epidural bolus dose per hour or reporting
inadequate analgesia after a bolus dose were excluded from the study. Level of sedation, motor
blockade depth, nausea and vomiting, shivering, maternal hypotension, fetal Apgar scores were
all monitored. There was no difference in degree of shivering, sedation, nausea and vomiting,
and degree of motor blockade. Reported levels of puritis were significantly higher in the fentanyl
group. Unfortunately, due to sample sizes the researchers were unable to find a difference
between the bupivacaine usage among the 3 neostigmine groups who received either 2, 4, or 8
mcg. The researchers mentioned how it is possible that .125% of Bupivacaine was a strong
enough dose to reach sensory blockade where fentanyl or neostigmine would not have made a
difference. They also mentioned that the women who were evaluated in this study were all very
pleased with their epidural and since any non-fully working epidurals were excluded, the
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adequacy between fentanyl and neostigmine could have just been due to highly functioning
epidural catheters.

An additional study conducted in 2004 evaluated the analgesia efficacy of epidural
neostigmine. The study was performed by Kaya and colleagues, inclusive of 80 patients
receiving elective cesarean section and receiving combined spinal epidural. All patients were to
receive 8 mg of Bupivacaine with 10 mcg of fentanyl and then randomly selected to receive
saline or 75, 150, 300 mcg of neostigmine after umbilical chord clamping. The researchers
concluded that neostigmine could provide analgesia in women post caesarean delivery. This
study mentioned that they were the first study to administer epidural neostigmine after a combine
spinal-epidural approach was placed. Exclusion criteria were patients heavier than 110kg, ASA
greater than 1, less than 18 years old and allergies to neostigmine or bupivacaine. The patients all
received a spinal of bupivacaine and fentanyl and then an epidural catheter. The epidural catheter
was only used to administer the studied dose once chord clamping was performed and removed
after surgery. Patient’s pain was managed post-op via morphine PCA pump. The number of
demand doses and morphine consumption was monitored at 8, 16 and 24 hours. Neostigmine
lowered pain but was not dose dependent. The time to the first pain complaint and PCA use was
prolonged in the neostigmine group. However total 24-hour morphine use was no different
between control and neostigmine groups. Additionally, results showed that time to ambulation
was shorter and patient satisfaction was higher in the groups that received neostigmine.
Neostigmine was administered after chord clamping when oxytocin was administered and
therefore could not assess any uterine contractions from muscarinic side effects. The researchers
stated that they found no negative maternal or fetal effects that would preclude epidural
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neostigmine from future clinical investigation. The study found that doses of 300 mcg were
associated with increased sedation among participants.
A 2003 study performed by Roelants and colleagues sought out to discover if epidural
neostigmine could lessen anesthetic requirements. Epidural neostigmine (4 mcg/kg) was added to
10 ml of .1% ropivacaine with and without 10mcg of sufentanil. Pain score, sensory level, and
motor blockade were all assessed 20 minutes after injection. The study concluded that when
neostigmine was added to 10mg of ropivacaine, the level of analgesia was equivalent to 20mg of
ropivacaine but was not as effective as sufentanil. There was no hemodynamic instability, or
negative side effects that were recorded among researchers. The researchers choose to use the
epidural route due to the spinal route having records of causing severe nausea. They also decided
to make the inclusion criteria laboring women, because they stated how reports show
neostigmine may be more efficacious in women compared to men, so gynecological and
obstetrics would be fitting for its use. All women were of ASA I-II and requesting of epidurals.
Exclusion criteria included, accidental dural puncture, multiple pregnancy, premature labor, and
nonvertex presentation. All anesthesiologists and residents who administered the dose, were
blind to the study. The recorded findings included hourly ropivacaine use, number of rescue
doses and time of total delivery from initial dose to delivery. The participants were randomized
into 4 groups. The first group received .2% 10ml (20mg ropivacaine), the others 3 groups
received ropivacaine with sufentanil and neostigmine alone or ropivacaine with neostigmine and
sufentanil. 101 patients participated in this study and 6 were excluded for requiring cesarean
delivery. Neostigmine had no effects on mother or fetal heart rate. The researchers concluded
that neostigmine with 10 mg of ropivacaine provided equal analgesia compared to 20mg of
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Ropivacaine with less motor blockade. The researchers found that dose to be safe for epidural
administration, however it had no effect on long term local anesthetic requirements.
A 2010 Randomized double blind study performed by Harjai and colleagues performed a
study evaluating two different doses of epidural neostigmine for postop analgesia. The study
included 90 females scheduled for lower abdominal surgery. The women were divided into three
groups of 30. Group I (control) received 9 ml of 1% lidocaine with 1 ml of normal saline. Group
II received 9 ml of 1% lidocaine and 100 mcg of neostigmine. Group III received 9 ml of 1%
lidocaine and 200 mcg of neostigmine. The cases were all ran with N20 and relaxant. At the
conclusion of the case, in recovery, all participants received their randomized dose. The
conclusion of the study showed dose independent extended duration of analgesia and dose
dependent sedation. Inclusion criteria included ASA level I-II women between the age 18-45
scheduled for lower intrabdominal surgery. Exclusion criteria included pregnant women,
allergies to local anesthetics, and epidural contraindications. After 15 minutes of epidural
administration; sensory and motor blockade were assessed. Level of sedation was also measured
on a ranked scale of 0-3 by responses to increasing stimuli. The time for rescue analgesia was
also monitored. The study stated there were no significant differences in participant
characteristics including age, height, and weight. The time for rescue analgesia was significantly
longer (210 min) in Groups II and III compared to Group I (130 min). Additionally, the amount
of rescue injections (IM diclofenac) was less (1-2) for Groups II and III with group I receiving
approximately 3-4. All candidates achieved approximately a T8 sensory level blockade with no
extreme variances. No candidate in either of the groups experienced a change in vital signs
greater than 15%. Groups II and III experienced mild levels of sedation with group I
experiencing none. The researchers believed the sedation to be beneficial for postoperative care
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due to enhanced analgesia and its ability to minimize cardiovascular and respiratory
complications. No side effects of puritis or respiratory depression were seen amongst any of the
participants, as is seen with opioid usage.
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combined spinal
then randomly
epidural.
selected to
Exclusion
receive saline,
criteria were
75, 150, 300
patients heavier
mcg of
than 110kg ,
neostigmine via ASA greater
epidural
than 1, less than
catheter after
18 years old and
chord
allergies to
clamping.
neostigmine or
Neostigmine
bupivacaine
was
administered
after chord
clamping

101 patients
participated.
participants
were
randomized
into 4 groups.
Epidural
neostigmine (4

All women were
of ASA I-II and
requesting of
epidurals.
Exclusion
criteria included,
accidental dural
puncture,

motor
blockade.
Reported
levels of
puritis were
significantly
higher in the
fentanyl
group

Time to the
first pain
complaint and
PCA use was
prolonged in
the
neostigmine
group. Total
24 hour
morphine use
was no
different
between
control and
neostigmine
groups. Time
to ambulation
was shorter
and patient
satisfaction
was higher in
the groups
that received
neostigmine
Neostigmine
had no effects
on mother or
fetal heart
rate. The
researchers
concluded
that

Neostigmine
was capable
of providing
analgesia in
women post
caesarean
delivery

The study
concluded
that when
neostigmine
was added to
10mg of
ropivacaine
the level of
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lessen LA
requirements

Harjai et Evaluating
al., 2010 two different
doses of
epidural
neostigmine
for postop
analgesia

Level I, Randomized
double blind study

mcg/kg) was
added to 10 ml
of .1%
ropivacaine
with and
without 10mcg
of sufentanil
The first group
received .2%
10ml (20mg
ropivacaine),
the others 3
groups received
ropivacaine
with sufentanil
and
neostigmine
alone or
ropivacaine
with
neostigmine
and sufentanil
Women were
divided into
three groups of
30. Group I
(control)
received 9ml of
1% lidocaine
with 1ml of
normal saline.
Group II
received 9ml of
1% lidocaine
and 100mcg of
neostigmine.
Group III
received 9ml of
1% lidocaine
and 200mcg of
neostigmine

multiple
pregnancy,
premature labor,
and nonvertex
presentation

neostigmine
with 10mg of
ropivacaine
provided
equal
analgesia
compared to
20mg of
Ropivacaine
with less
motor
blockade

analgesia
was
equivalent to
20mg of
ropivacaine
but was not
as effective
as sufentanil
was

90 females
scheduled for
lower abdominal
surgery.
Inclusion criteria
included ASA
level I-II women
between the age
18-45 scheduled
for lower
intrabdominal
surgery.
Exclusion
criteria included
pregnant women,
allergies to local
anesthetics, and
epidural
contraindications

Time for
rescue
analgesia was
significantly
longer (210
min) in
Groups II and
III compared
to Group I
(130 min).
Additionally,
the amount of
rescue
injections (IM
diclofenac)
was less (1-2)
for Groups II
and III with
group I
receiving
approximately
3-4

Epidural
Neostigmine
extended the
duration and
depth of
analgesia
without
negative
muscarinic
side effects.
The groups
receiving
neostigmine
had dose
dependent
sedative
effects.
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Discussion
Summary of the Evidence

After reviewing the evidence, the usage of epidural neostigmine does seem to have a
place in an anesthesia practitioner’s arsenal. All seven RCTs showed an enhancement in patient
analgesia and patient satisfaction without serious complications. Six of the seven articles
included laboring women with one article included participants having orthopedic procedures.
There have been well documented reports of severe nausea that is experienced when neostigmine
is administered intrathecally. This fact is why only RCTs where neostigmine was administered
epidurally were evaluated except for the one study. None of the RCTs showed harmful
muscarinic effects towards the patient, mother, or fetus. This was a positive and reassuring result
that supports the safety of this drug and route for further usages and studies to be conducted.
One of the studies by Roelant’s and colleagues did not show neostigmine’s analgesia
effects to be as efficacious as sufentanil, but it was equivalent to doubling the LA dosage. This
result supports the hypothesis that if opioids are not desired due to their negative profile, LAs are
reaching their upper safe limit, or motor blockade is too dense then Neostigmine may be a
beneficial option for a patient.
Purpose
Eligibility Criteria: Articles found to be eligible for review were found to fit within the
constraints of the original PICO question.
Population (P): Anesthesia Providers who participate in epidural management
Intervention (I): Educating about epidural Neostigmine analgesia
Comparison (C): Comparing epidural neostigmine knowledge before and after education.
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Outcome (O): Improve provider knowledge on methods to improve analgesia when additional
local analgesia is contraindicated or opioid puritis is unwanted.
All articles that fit these constraints were evaluated. Any study regarding the epidural usage on
animals or rats were not accepted for review.
Information Sources
Databases that were used for this study included The Cumulative Index to Nursing and
Allied Health Literature (CINAHL), Cochrane Library, and PUBMED.
Search Strategy
When searching CHINAL for “Epidural analgesia” and “neostigmine” 20 results were
displayed. After further narrowing of results with full text and scholarly journal criteria, 16
results were populated and evaluated. Upon searching Cochrane Library, key words “epidural
analgesia” and “neostigmine” were utilized. Initial efforts populated 10,500 results. When
rephrasing Boolean terms to “epidural neostigmine” and “analgesia” 503 results were populated.
When narrowing the time range within the past 10 years, 250 results were produced. These
abstracts and titles were reviewed to include only randomized control trials. A total of seven
articles were chosen and were deemed fitting within the PICO constraints.

Definition of terms

Neuraxial Analgesia: The goal of neuraxial anesthesia is to block pain transmission from area
of injury, disease, or surgical intervention.16 Spinal and epidural analgesia are known as central
neuraxial blockade because they involve placement of local anesthetics onto or nearby the spinal
cord. Spinal and epidural blockade share much of the same anatomy and physiology but are
distinct in their anatomic, physiologic, and clinical features.16
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Epidural: An epidural is an injection of a local anesthetic into the space directly outside the dura
matter of the spinal cord. What is clinically important about spinal and epidural analgesia is that
the primary site of action for local anesthetics is on the nerve roots within the spinal cord.16

Acetylcholine: In the autonomic nervous system, acetylcholine (ACh) is the neurotransmitter in
the preganglionic sympathetic and parasympathetic neurons. In the peripheral nervous system,
ACh is the neurotransmitter at the neuromuscular junction between the motor nerve and skeletal
muscle. In the central nervous system, ACh is found primarily in interneurons.16

Neostigmine: Neostigmine is a carbamic acid ester of alcohols and contains a quaternary amino
group. This agent forms a carbamyl-ester complex at the esteratic site of cholinesterase. The
indirect effect of cholinesterase inhibitors is increasing the concentration of endogenous
acetylcholine around cholinergic receptors.
Opioid: “The development of synthetic drugs with morphine-like properties has led to the use of
the term opioid to refer to all exogenous substances, natural and synthetic, that bind specifically
to any of several subpopulations of opioid receptors and produce at least some agonist
(morphine-like) effects. Opioids are unique in producing analgesia without loss of touch,
proprioception, or consciousness.”14

Methodology
Goals and Outcomes
The goals and outcomes of this project are to identify any gaps or flaws in the current
management of analgesia via the epidural route that may benefit from new research and
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evidence. If there are any weaknesses in the hospitals current implemented protocols, then
opportunities will be investigated for delivering evidence that will improve those protocols. Any
currently implemented protocols that are strong or will assist in improving the implementation of
the best current evidence-based practice will be further strengthened and encouraged to continue
their practice.
Specific
Certified Registered Nurse anesthetists, student registered nurse anesthetist,
anesthesiologists, and anesthesia residents will be educated on the benefits of epidural
neostigmine.
Measurable
The participants will be educated on the topic and provided a voluntary questionnaire
before and after an educational presentation, which will evaluate any gained knowledge on the
topic. In addition, the questionnaire will analyze the likeliness that practitioners will utilize
neostigmine epidurally in their future practice after having received the presentation.
Attainable
The completion of voluntary anonymous pre and post questionnaires should be attainable,
especially if the questionnaires and education are presented in environments that are highyielding for epidural procedures, such as obstetrics.
Realistic
CRNAs, SRNAs, anesthesiologists, and residents are in constant communication via
email and daily meetings. Therefore, the opportunity to present this current evidence should be
achievable.
Timely

26
Any participants that partake in this educational presentation and survey will be allotted
six months to complete the pre-survey, read the educational power point, and complete the posteducational survey.
Description of the Program Structure
A SWOT analysis represents the strengths, weaknesses, opportunities, and threats of a
project being designed. The purpose of the SWOT analysis is for a researcher to understand the
project’s strengths and weaknesses while being cognoscente of possible opportunities.13 The
strengths and weaknesses tend to arise from the project or organization itself.13 In addition many
of the opportunities and threats that arise tend to be external circumstances that arise to the
project.
Strengths
The strengths of a SWOT analysis represent areas that an organization does exceptionally
well and succeeds in.13 The hospital takes exceptional pride in providing adequate analgesia
during the perioperative and postoperative period. The addition of neostigmine into the daily
practice of analgesia management aligns well with the organization’s goal. The goal of providing
pain relief while minimizing adverse side effects is at the foremost of this project’s intent as well
as the organization’s daily mission.
Weakness
The weakness in SWOT analysis represents areas that need improvement. In one’s
analysis, these weaknesses need to be decided upon if their salvaging is possible and if required
resources are even available.13 In addition, when resolving these weaknesses, how will their
resolution benefit the organization. A possible weakness towards the implementation of
neostigmine with epidurals may be the fear of unwanted muscarinic side effects that come from
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anti-cholinesterase medications. Another weakness is that there is no current evidence to show
that neostigmine provides superior analgesia compared to opioids. This fact may lead
practitioners to continue using their current regimen that has been successful. Additionally,
enhanced and extended analgesia is well known to be exhibited with the supplemental addition
of intrathecal steroids such as Decadron. This knowledge and current safety profile may make
practitioners resistant to try alternate methods of enhancing analgesia compared to proven
successful techniques. Lastly, there may be resistance due to personal beliefs and biases among
individual practitioners.
Opportunities
The opportunities section analyzes the given strengths and any potential to grow these
strengths to further improve one’s goal.13 Also, assessing the weaknesses and deciding how their
resolution will create positive impacts on one’s goal or if eliminating their status all together
would be superior rather than attempting to rectify them altogether.13

A high proportion of obstetric malpractice claims are the result of pain during anesthesia
compared to nonobstetric claims.9. Circumstances arise where labor is escalating rapidly and the
sacral blockade efficacy may not suffice. During these circumstances, large volumes of local
anesthetic may improve sacral analgesia.9 However if the efficacy of sensory blockade is optimal
but the patient is still expressing pain, then the blockade’s density may be inadequate.9 These
instances can be resolved with the administration of a more concentrated local anesthetic. 9
However these options in efforts of deepening the block run the possibility of high neuraxial
levels and possibly reaching the upper limit of safe LA dosages.
Using Neostigmine can enhance the efficacy of analgesia without some of the side effects
associated with opioid use and risks of LAST from larger LA requirements. The intravenous use
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of opioids reduces pain and increases the release of acetylcholine in the spinal cord’s dorsal
horn.2 This effect has also been proven to be enhanced with the injection of intrathecal
neostigmine.2 Neostigmine administration in conjunction with alternative medication in neuraxial
anesthesia is associated with a reduced dosage of LA required during labor and postoperatively
following cesarean section.4 This 2015 systematic review by Cossu and colleagues showed how
neuraxial administration of neostigmine significantly minimized local anesthetic usage without
causing serious negative side effects to the fetus or mother.4 However, due to the occurrence of
nausea and vomiting when given subarachnoid, neostigmine should only be given via the
epidural route.4

Threats
The threats that may arise in one’s analysis are going to be obstacles that one deems
detrimental to the organization’s goals or the project altogether.13 These obstacles may consist of
current competition, regulations, current practice beliefs, policies, and personal beliefs. The goal
of neutralizing initial threats of resistance would be by educating practitioners regarding the rates
and statistics of the negative side effects opioids produce when administered epidurally.
Additionally, educating practitioners that if enhanced blockade is desired and local anesthetic
dosages are maxed out, then neostigmine can be a valuable option; especially if the unwanted
side effects of opioids are highly undesired. The biggest threat appears to be disrupting the
current standards of practice that have a high profile for safety and effectiveness, while
attempting to convince practitioners that there may be an additional safe option. The main
strategy in mitigating this threat is through education and presenting strong evidence that
supports the claims of neostigmine’s epidural analgesic benefits.
Theoretical Framework
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Selecting a Nursing Theory allows one to better focus efforts on research in a way that
can be better suited for individual circumstances.13 When one implements nursing theory into
work, self, personal values, and assumptions then all of these factors can be evaluated to allow
for a more holistic process. A theory that will be specifically utilized during this research is
Johnson’s Behavioral Systems Model Theory. This theory emphasizes how humans are systems
that are behaving in an environment that is affected by internal and external factors.13 This theory
is excellent for evaluating the responses from anesthesia faculty after being educated on the
current evidence regarding epidural neostigmine. This theory will help guide and understand the
resistance to change or acceptance toward neostigmine’s use. The resistance or acceptance may
come from internal conflicts such as assumptions of best practice or external conflicts due to
protocols, financial restraints, and even patient acceptance or refusal. Many circumstances can
affect the acceptance or rejection of new evidence and this theory will assist in guiding and
understanding how providers respond after receiving new evidence.
Methodology
Setting and Participants
This project will be conducted amongst the Florida International Alumni List. The
participants included Certified Registered Nurse Anesthetist alumni. This group of participants
routinely engages in the use of epidural analgesia and provides an excellent volume of
knowledge. Currently, there are approximately 60 CRNAs enrolled on the list.

Description of approach and project procedures
This project will be conducted by inviting the previously mentioned participants to
engage in an online survey via email. The data that will be conducted may include the years of
employment and experience, age, location of training, and provider role. The providers will be
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presented a questioner regarding their knowledge of supplemental medications that may be
safely administered in combination with epidural local anesthetics to enhance analgesia. After
the survey, an educational video will be presented on current research and knowledge of epidural
neostigmine. After the video has been viewed, participants will be asked to complete a posteducational survey. The survey will evaluate any new knowledge gained and the possibility of
providers implementing this new research into their practice.

Protection of Human Subjects
The subjects will all be emailed privately from the primary investigator. All responses
will be anonymously submitted. The primary investigator will ensure all responses are
confidential and the software used to collect responses ensures anonymous polls. All participants
will have the option to withdraw their responses or not participate.

Data Collection
Questions will be presented in a manner which assesses practitioners beliefs in the
benefits of additional pharmacological methods to enhance epidural analgesia. A 4-point Likerttype scale ranging from 1 (strongly disagree) to 4 (strongly agree) will be used to assess if they
have heard of neostigmine epidurally, if they would use it after completing this survey, if they
believe additional medications such as opioids, steroids enhance their epidural analgesia.

Data management and analysis plan
Data will all be held and evaluated by the primary investigator. The anonymous results
will only be accessible by the primary investigator and be stored in an electronic database.

Discussion of the results with implications to advanced nursing practice
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If the results from the survey conveyed that knowledge was gained, then the project
would be deemed a success. In addition, if practitioners strongly agreed in implementing
neostigmine into their pharmaceutical repertoire, then this would be a strong success. The
purpose of this project is educating hospital staff who use epidurals daily for patient analgesia. If
a competency course could show knew knowledge gained in the field of epidural management,
then change could possibly occur in real practice. This educational competency has the potential
to have a strong impact because the participants have great accessibility to these pharmacological
supplies and possess advanced epidural management skills.

Timeline
Project Tasks
1. Develop the education intervention
2. Develop the questionnaire
3. Request CBMCS permission
4. Receive IRB approval
5. Choose an electronic database
6. Create and send study invitation
7. Administer pretest questionnaires
8. Perform educational intervention
9. Administer posttest questionnaire
10. Record participants responses
11. Analyze the anonymous data

Results
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The patient demographics are depicted below in the table from the voluntary participants.
There was a total of seven participants. Five (71%) of the participants were male, while two
(28%) were female. The age range of the participants were asked. Two (66%) of the participants
were between the ages of 25-30 and 1 (33%) was between the age of 31-40. Other age ranges
were provided, but the remaining four participants preferred not to answer. The level of
education was asked. Four (51%) participants had a bachelor’s degree, while two (28%) had a
Masters and 1 (14%) had a Doctorate degree. Lastly, the years of experience was asked. Four
(57%) of the participants had 0-2 years of working experience, while two (28%) had 2-4 years of
experience and one (14%) had 6-10 years of experience. Two participants did not complete the
posttest survey and were therefore not included in the final assessment.

Demographics
Gender
Male
Female
Age
25-30
31-40
Prefer not to
answer

N(%)

5 (71%)
2 (28%)

2 (66%)
1 (33%)
4

Level of Education
Bachelors
Masters
Doctorate

4 (51%)
2 (28%)
1 (14%)

Years of experience
0-2
2-4.
4-6.
6-10.

4 (57%)
2 (28%)
0
1 (14%)
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All participants were consented for voluntary participation. After consent, patient
demographics were collected. Then a pre-test consisting of eleven questions was provided. After
the questionnaire, a link to an educational video regarding epidural neostigmine was provided.
After the video was watched participants were provided a random ID number and given a post
survey test that consisted of the original eleven pre-test questions. The same questions were
provided to see if learning had occurred. The eleven questions that were provided in the pre and
post survey consisted of:

1. Annual Medical Claims were the highest for what specialty, totaling $15million?
a. Obstetrics b. Regional c. Cardiac d. Urology
2. The intravenous use of opioids reduce pain and increase the release of what in the spinal
cord’s dorsal horn:
a. Dopamine
b. Serotonin
c. Acetylcholine
d. Norepinephrine
3. What chemical is released by in the spinal chord when neuraxial neostigmine is
administered?
a. Dopamine
b. Serotonin
c. Acetylcholine
d. Norepinephrine
4. What is a possible consequence of neuraxial opioids?
a) Pruritis
b) Respiratory depression
c) Fetal Respiratory depression
d) All of the above
5. What are the symptoms of Local Anesthetic Systemic Toxicity?
a. Bradycardia
b. Hypotension
c. Respiratory Depression
d. All of the Above
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6. What additional Medications can be administered neuraxially in addition to local
anesthetics to enhance analgesia?
a) Clonidine
b) Opioids
c) Neostigmine
d) Precedex
e) Gabapentin
f) All of the above
7. When compared to epidural opioids how efficacious has epidural neostigmine at
providing analgesia proven to be?
a. More effective
b. Less effective
c. Equally effective
8. What effect did neostigmine have when administered via the epidural route to pregnant
mothers?
a. Headache
b. Sedation
c. Nausea and Vomiting
d. Confusion
9. What was an effective/ safe dose for epidural neostigmine administration?
a) 40mcg
b) 300mcg
c) 1mcg
d) 10mcg
10. How likely are you to use alternative therapies in to enhance epidural analgesia
a)
b)
c)
d)

Most likely
Somewhat likely
Somewhat unlikely
Most unlikely

11. How likely are you to utilize a single dose of epidural neostigmine to enhance the
analgesia of a patient in addition to Local Anesthetics?
1. Most likely
2. Somewhat likely
3. Somewhat unlikely
4. Most unlikely

Pre Survey
The results from the pre and post survey are provided below. The randomized anonymous
numbers provided were utilized to be able to compare the five participants pre and post survey
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responses. Participant one scored an 11% on the pretest and after the educational video, a score
of 44% was achieved. This participant showed that education had occurred. Participant two
scored a 44% on the pre and posttest. They answered different questions correctly on the posttest
than they did on the first, showing that some education did occur, but mistakes were still made.
Participant three scored a 44% on the pre and an 88% on the post test, showing education did
occur. Participant four scored an 11% on the pre and a 0% on the post. This participant may have
not been paying full attention to the questions or did not possibly understand the material.
Participant five scored an 11% on the pretest and an 88% on the posttest, showing a substantial
difference in test scores after watching the educational video. In summary, three of the
participants showed improvement in the test scores after watching the educational video while
one did worse, and another received the same score. Provided below is the table comparing the
answers of the five participants pre and post test scores.

Post Survey Test results are displayed in the Table below:
Post Test
Correct
Question # Answers
1
2

% Correct
1
20%
2
40%
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3
4
5
6
7
8
9

4
2
3
2
2
3
3

80%
40%
60%
40%
40%
60%
60%

Assessment Questions and Implications to Advanced Nursing Practice
Provided below are questions that assessed the participants likelihood to use alternative
medications besides opioids and local anesthetics in the management of epidural analgesia.
Question 10 asked how likely participants are to use alternative therapies rather than local
anesthetic and opioids to enhance epidural analgesia. Two participants (40%) said extremely
likely. An additional two participants (40%) said somewhat likely and one participant (20%) said
neither likely nor unlikely. This showed that practitioners are willing to try alternative
approaches to enhance epidural analgesia if patients will benefit. Additionally, question eleven,
asked the likelihood that after watching the video on epidural neostigmine for enhanced
analgesia, would the participant be willing to use neostigmine in their daily practice. Based upon
the results, two participants would be extremely likely to use epidural neostigmine. This result
shows that the YouTube presentation provided a positive educational experience which may
influence practitioners to utilize epidural neostigmine. The categories extremely likely,
somewhat unlikely, and neither likely nor unlikely all had one participant choose that response.
These results showed that the video may not have provided enough evidence to convince a
provider to alter their daily practice or they just may not be willing to change, their current
practice base on the information provided. The participant that answered neither likely nor
unlikely may not have been convinced either or possibly works in a department where they don’t
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perform many epidural such as a surgical center, or anesthesiologists perform the neuraxial
anesthesia.

Limitations
One of limitations to the DNP project was the small size of participants. A larger
participating group would have been more beneficial to assess the beliefs and evidence of
learning achieved from the DNP educational module. Another limitation may have been the use
of the internet. It is possible that many email invitations were not opened by FIU alumni. It is
also possible that many CRNAs found this topic less beneficial and choose not to participate
because they do not engage in obstetrics where there is a high use of epidurals.
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Summary
Overall, the DNP project had a total of five participants fully complete the pretest, education
video and posttest. The results showed that learning indeed did occur and based off of the
responses, some practitioners would be willing to utilize neostigmine for enhanced epidural
analgesia based upon the information provided. Question 10 from the post test survey asked how
likely participants are to use alternative therapies rather than local anesthetic and opioids to
enhance epidural analgesia. Two participants (40%) said extremely likely. An additional two
participants (40%) said somewhat likely. This showed that practitioners are willing to try
alternative approaches to enhance epidural analgesia if patients will benefit. Based upon the
results, two participants would be extremely likely to use epidural neostigmine. This result
shows that the YouTube presentation provided a positive educational experience which may
influence practitioners to utilize epidural neostigmine. In conclusion, the DNP project showed
that practitioners are willing to use alternate modalities when managing epidural analgesia and
video modalities such as YouTube can be a beneficial way to present new learning material.
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CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“Improve Knowledge in Epidural Neostigmine for Enhanced Analgesia”

SUMMARY INFORMATION
Things you should know about this study:









Purpose: Educational module to improve knowledge in utilizing epidural neostigmine
for enhanced analgesia
Procedures: If you choose to participate, you will be asked to complete a pre test
watch a voice PowerPoint and then a post test
Duration: This will take about a total of 20 minutes total.
Risks: The main risk or discomfort from this research is minimal. There will be minimal
risks involved with this project, as would be expected in any type of educational
intervention, which may have included mild emotional stress or mild physical
discomfort from sitting on a chair for an extended period of time, for instance.
Benefits: The main benefit to you from this research is increase the participants
knowledge in utilizing epidural neostigmine for enhanced analgesia.
Alternatives: There are no known alternatives available to you other than not taking
part in this study.
Participation: Taking part in this research project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE PROJECT
You are being asked to be in a quality improvement project. The goal of this project is to
improve health care provider knowledge on the use epidural neostigmine for enhanced
analgesia

DURATION OF THE PROJECT
Your participation will require about 20 minutes of your time. If you decide to participate you
will be 1 of 10 participants.
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PROCEDURES
If you agree to be in the project, we will ask you to do the following things:
If you agree to be in the study, we will ask you to do the following things:
1. Complete an online 10 question pre-test survey via Qualtrics, an Online survey product for
which the URL link is provided
2. Review the educational PowerPoint Module lasting 10 minutes via Qualtrics, an Online survey
product for which the URL link is provided.
3. Complete the online 10 question post-test survey via Qualtrics, an Online survey product for
which the URL link is provided.
RISKS AND/OR DISCOMFORTS
The main risk or discomfort from this research is minimal. There will be minimal risks involved
with this project, as would be expected in any type of educational intervention, which may have
included mild emotional stress or mild physical discomfort from sitting on a chair for an
extended period of time, for instance.
BENEFITS
The following benefits may be associated with your participation in this project: An
increased understanding regarding the use of epidural neostigmine to enhance ones level of
analgesia.
The overall objective of the program is to increase the quality of healthcare delivery and
improve healthcare outcomes for our patients.
ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project.
However, if you would like to receive the educational material given to the participants in this
project, it will be provided to you at no cost.

CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent
provided by law. If, in any sort of report, we might publish, we will not include any
information that will make it possible to identify you as a participant. Records will be stored
securely, and only the project team will have access to the records.
PARTICIPATION: Taking part in this research project is voluntary.

COMPENSATION & COSTS
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There is no cost or payment to you for receiving the health education and/or for participating in
this project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent at such time that they feel it is in the best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Frank Duffin at fduff004@fiu.edu or Dr. Fernando Alfonso at
FAlfonso@FIU.edu.
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights pertaining to being a subject in this
project or about ethical issues with this project, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. By
clicking on the “consent to participate” button below I am providing my informed consent.
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Pretest and Posttest Questionnaire:
Epidural Neostigmine for Enhanced Analgesia
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of CRNAs pertaining to the
utilization of epidural neostigmine for enhanced analgesia.
Please answer the question below to the best of your ability. The questions include demographic
information and knowledge of methadone utilization in adult surgical patients. Questions are
either in multiple choice or likert style format and are meant to measure the CRNAs knowledge
of the effectiveness of intraoperative methadone reducing post-operative opioid consumption.
PERSONAL INFORMATION
1. Gender: Male Female Other________
2. Age: ______

3. Ethnicity: Hispanic, Caucasian, African American, Asian, Other_______________

4. Position/Title: _________________________________
5. Level of Education: Associates Bachelors Masters Doctoral (DNP, DNAP, EdD, PhD)
_______
6. Years of experience: Less than 1 year 1 to 5
6 to 10 more than 10 years
QUESTIONNAIRE
12. Annual Medical Claims were the highest for what specialty, totaling $15million?
a. Obstetrics b. Regional c. Cardiac d. Urology
13. The intravenous use of opioids reduce pain and increase the release of what in the
spinal cord’s dorsal horn:
a. Dopamine
b. Serotonin
c. Acetylcholine
d. Norepinephrine
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14. What chemical is released by in the spinal chord when neuraxial neostigmine is
administered?
e. Dopamine
f. Serotonin
g. Acetylcholine
h. Norepinephrine
15. What is a possible consequence of neuraxial opioids?
e) Pruritis
f) Respiratory depression
g) Fetal Respiratory depression
h) All of the above
16. What are the symptoms of Local Anesthetic Systemic Toxicity?
e. Bradycardia
f. Hypotension
g. Respiratory Depression
h. All of the Above
17. What additional Medications can be administered neuraxially in addition to local
anesthetics to enhance analgesia?
g) Clonidine
h) Opioids
i) Neostigmine
j) Precedex
k) Gabapentin
l) All of the above
18. When compared to epidural opioids how efficacious has epidural neostigmine at
providing analgesia proven to be?
d. More effective
e. Less effective
f. Equally effective
19. What effect did neostigmine have when administered via the epidural route to
pregnant mothers?
e. Headache
f. Sedation
g. Nausea and Vomiting
h. Confusion
20. What was an effective/ safe dose for epidural neostigmine administration?
e) 40mcg
f) 300mcg
g) 1mcg
h) 10mcg
21. How likely are you to use alternative therapies in to enhance epidural analgesia
e) Most likely
f) Somewhat likely
g) Somewhat unlikely
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h) Most unlikely
22. How likely are you to utilize a single dose of epidural neostigmine to enhance the
analgesia of a patient in addition to Local Anesthetics?
1. Most likely
2. Somewhat likely
3. Somewhat unlikely
4. Most unlikely
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